Top compounds associated with response to RBM20


Feature Type Standardized
Nominal ANOVA
mRNA simvastatin CTRPv2 pan-cancer AAC -0.077 0.07
mRNA navitoclax:birinapant (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.069 0.07
mRNA BRD-K27188169 CTRPv2 pan-cancer AAC -0.11 0.07
mRNA Bexarotene CTRPv2 pan-cancer AAC 0.07 0.07
mRNA CD-1530 CTRPv2 pan-cancer AAC 0.073 0.07
mRNA PHA-665752 CCLE pan-cancer AAC -0.089 0.07
mRNA A-804598 CTRPv2 pan-cancer AAC -0.086 0.07
mRNA itraconazole CTRPv2 pan-cancer AAC -0.072 0.07
mRNA QL-XII-61 GDSC1000 pan-cancer AAC -0.097 0.07
mRNA BRD-K28456706 CTRPv2 pan-cancer AAC 0.067 0.08
Download CSV